Literature DB >> 16684496

Diuretic resistance in heart failure.

Srinivas Iyengar1, William T Abraham.   

Abstract

The use of diuretics for the treatment of heart failure (HF) is ubiquitous in any basic HF medical regimen. Although initially these drugs clearly show benefit by relieving symptomatic episodes of decompensated HF, long-term use of these drugs can lead to a "diuretic-resistant" state and is associated with an increased risk of morbidity and mortality. A number of factors may be responsible for this, including dietary noncompliance, inadequate diuretic dosing or methods of administration, and concomitant use of certain medications. Diuretics themselves may set in motion an iatrogenic cardiorenal syndrome leading to worsening renal function and diuretic resistance. The methods for overcoming this resistance are varied and require a focused approach with emphasis on relieving the congestive symptoms related to HF while attempting to preserve renal function and minimize any untoward systemic effects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16684496     DOI: 10.1007/s11897-006-0030-x

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN: 1546-9530


  27 in total

1.  Mechanism of impaired natriuretic response to furosemide during prolonged therapy.

Authors:  N R Loon; C S Wilcox; R J Unwin
Journal:  Kidney Int       Date:  1989-10       Impact factor: 10.612

2.  Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.

Authors:  Anne L Taylor; Susan Ziesche; Clyde Yancy; Peter Carson; Ralph D'Agostino; Keith Ferdinand; Malcolm Taylor; Kirkwood Adams; Michael Sabolinski; Manuel Worcel; Jay N Cohn
Journal:  N Engl J Med       Date:  2004-11-08       Impact factor: 91.245

3.  Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion.

Authors:  T P Dormans; J J van Meyel; P G Gerlag; Y Tan; F G Russel; P Smits
Journal:  J Am Coll Cardiol       Date:  1996-08       Impact factor: 24.094

4.  Dopamine does not enhance furosemide-induced natriuresis in patients with congestive heart failure.

Authors:  D L Vargo; D C Brater; D W Rudy; S K Swan
Journal:  J Am Soc Nephrol       Date:  1996-07       Impact factor: 10.121

5.  Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

Authors: 
Journal:  N Engl J Med       Date:  1987-06-04       Impact factor: 91.245

6.  Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance.

Authors:  J J van Meyel; P Smits; T Dormans; P G Gerlag; F G Russel; F W Gribnau
Journal:  J Intern Med       Date:  1994-04       Impact factor: 8.989

7.  Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients.

Authors:  Brian E Jaski; Jae Ha; Bart G Denys; Sumant Lamba; Robin J Trupp; William T Abraham
Journal:  J Card Fail       Date:  2003-06       Impact factor: 5.712

8.  Isolated ultrafiltration in moderate congestive heart failure.

Authors:  P G Agostoni; G C Marenzi; M Pepi; E Doria; A Salvioni; G Perego; G Lauri; F Giraldi; S Grazi; M D Guazzi
Journal:  J Am Coll Cardiol       Date:  1993-02       Impact factor: 24.094

9.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.

Authors:  M Packer; M R Bristow; J N Cohn; W S Colucci; M B Fowler; E M Gilbert; N H Shusterman
Journal:  N Engl J Med       Date:  1996-05-23       Impact factor: 91.245

10.  Metolazone in treatment of severe refractory congestive cardiac failure.

Authors:  A Kiyingi; M J Field; C C Pawsey; J Yiannikas; J R Lawrence; W J Arter
Journal:  Lancet       Date:  1990-01-06       Impact factor: 79.321

View more
  5 in total

1.  Compensatory Distal Reabsorption Drives Diuretic Resistance in Human Heart Failure.

Authors:  Veena S Rao; Noah Planavsky; Jennifer S Hanberg; Tariq Ahmad; Meredith A Brisco-Bacik; Francis P Wilson; Daniel Jacoby; Michael Chen; W H Wilson Tang; David Z I Cherney; David H Ellison; Jeffrey M Testani
Journal:  J Am Soc Nephrol       Date:  2017-07-24       Impact factor: 10.121

2.  First-in-Human Experience With Peritoneal Direct Sodium Removal Using a Zero-Sodium Solution: A New Candidate Therapy for Volume Overload.

Authors:  Veena S Rao; Jeffrey M Turner; Matthew Griffin; Devin Mahoney; Jennifer Asher; Sangchoon Jeon; Peter S Yoo; Nabil Boutagy; Attila Feher; Albert Sinusas; F Perry Wilson; Fredric Finkelstein; Jeffrey M Testani
Journal:  Circulation       Date:  2020-01-08       Impact factor: 29.690

3.  Spot urine sodium excretion as prognostic marker in acutely decompensated heart failure: the spironolactone effect.

Authors:  João Pedro Ferreira; Nicolas Girerd; Pedro Bettencourt Medeiros; Mário Santos; Henrique Cyrne Carvalho; Paulo Bettencourt; David Kénizou; Javed Butler; Faiez Zannad; Patrick Rossignol
Journal:  Clin Res Cardiol       Date:  2015-11-28       Impact factor: 5.460

4.  Relationship of Loop Diuretic Dosing and Acute Changes in Renal Function during Hospitalization for Heart Failure.

Authors:  Mostafa El-Refai; Olesya Krivospitskaya; Edward L Peterson; Karen Wells; L Keoki Williams; David E Lanfear
Journal:  J Clin Exp Cardiolog       Date:  2011-11-22

5.  Insufficient natriuretic response to continuous intravenous furosemide is associated with poor long-term outcomes in acute decompensated heart failure.

Authors:  Dhssraj Singh; Kevin Shrestha; Jeffrey M Testani; Frederik H Verbrugge; Matthias Dupont; Wilfried Mullens; W H Wilson Tang
Journal:  J Card Fail       Date:  2014-04-02       Impact factor: 5.712

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.